Crestline Management, LP Ideaya Biosciences, Inc. Transaction History
Crestline Management, LP
- $1.88 Billion
- Q3 2024
A detailed history of Crestline Management, LP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Crestline Management, LP holds 24,857 shares of IDYA stock, worth $595,076. This represents 0.04% of its overall portfolio holdings.
Number of Shares
24,857Holding current value
$595,076% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding IDYA
# of Institutions
213Shares Held
81MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$163 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$125 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$124 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$115 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$96.1 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.15B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...